Your session is about to expire
← Back to Search
Regorafenib for Liver Cancer
Study Summary
This trial is testing whether adding electromagnetic fields to the drug Regorafenib can help people with liver cancer live longer without the cancer growing, compared to people who just take Regorafenib.
- Liver Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 1 & 2 trial • 495 Patients • NCT02024607Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this an unprecedented research endeavor?
"Currently, Regorafenib is the subject of 58 ongoing investigations in 418 cities and 30 nations. This drug was first trialled by Bayer in 2014 with 38 participants, attaining Phase 2 approval. Since then, a further 82 examinations have been executed."
What ailments can Regorafenib be employed to combat?
"Patients who have received anti-VEGF therapy, established advanced directives, and were prescribed Sorafenib can be administered Regorafenib to treat their condition."
Has the FDA sanctioned Regorafenib for use?
"Regorafenib has been classified with a safety score of 2 due to the limited evidence supporting its efficacy, although there is some proof that it can be used without major risk."
What is the upper limit for individuals participating in this medical study?
"Affirmative. Clinicaltrials.gov has records that this research is actively enrolling patients, with the first posting having been made on January 26th 2021 and being updated as recently as October 26th 2022. 25 participants are needed to be recruited from 1 medical site."
Are there any extant reports pertaining to the efficacy of Regorafenib?
"At present, Regorafenib is the subject of 58 ongoing trials with 7 at Phase 3. Most are located in Commack, New york; however 1205 other sites have also launched research initiatives for this medication."
Are there any vacant slots for participants in this trial?
"Affirmative. According to clinicaltrials.gov, this research endeavour was first shared on January 26th 2021 and is actively seeking volunteers for participation. 25 recruits are being sought out from a single medical centre."
Share this study with friends
Copy Link
Messenger